Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q904153> ?p ?o }
Showing triples 1 to 56 of
56
with 100 triples per page.
- Q904153 subject Q9019796.
- Q904153 abstract "Sevelamer (rINN) (/sɛˈvɛləmər/ or /sɛˈvɛləmɪər/) is a phosphate binding drug used to treat hyperphosphatemia in patients with chronic kidney disease. When taken with meals, it binds to dietary phosphate and prevents its absorption. Sevelamer was invented and developed by GelTex Pharmaceuticals. Sevelamer is currently marketed by Sanofi under the trade names Renagel (sevelamer hydrochloride) and Renvela (sevelamer carbonate).".
- Q904153 atcPrefix "V03".
- Q904153 atcSuffix "AE02".
- Q904153 casNumber "52757-95-6".
- Q904153 drugbank "DB00658".
- Q904153 fdaUniiCode "941N5DUU5C".
- Q904153 iupacName "co-N,N'-diallyl-1,3-diamino-2-hydroxypropane)".
- Q904153 iupacName "poly(allylamine-".
- Q904153 pubchem "3085017".
- Q904153 thumbnail Sevelamer.png?width=300.
- Q904153 wikiPageExternalLink a601248.html.
- Q904153 wikiPageExternalLink www.renagel.com.
- Q904153 wikiPageExternalLink www.renvela.com.
- Q904153 wikiPageWikiLink Q105522.
- Q904153 wikiPageWikiLink Q133087.
- Q904153 wikiPageWikiLink Q160184.
- Q904153 wikiPageWikiLink Q1641062.
- Q904153 wikiPageWikiLink Q1641384.
- Q904153 wikiPageWikiLink Q167198.
- Q904153 wikiPageWikiLink Q169324.
- Q904153 wikiPageWikiLink Q178436.
- Q904153 wikiPageWikiLink Q178623.
- Q904153 wikiPageWikiLink Q181699.
- Q904153 wikiPageWikiLink Q2294.
- Q904153 wikiPageWikiLink Q275419.
- Q904153 wikiPageWikiLink Q30.
- Q904153 wikiPageWikiLink Q408.
- Q904153 wikiPageWikiLink Q40878.
- Q904153 wikiPageWikiLink Q41861.
- Q904153 wikiPageWikiLink Q420060.
- Q904153 wikiPageWikiLink Q423083.
- Q904153 wikiPageWikiLink Q45959.
- Q904153 wikiPageWikiLink Q496.
- Q904153 wikiPageWikiLink Q49970.
- Q904153 wikiPageWikiLink Q62500.
- Q904153 wikiPageWikiLink Q653971.
- Q904153 wikiPageWikiLink Q661790.
- Q904153 wikiPageWikiLink Q736715.
- Q904153 wikiPageWikiLink Q824258.
- Q904153 wikiPageWikiLink Q9019796.
- Q904153 atcPrefix "V03".
- Q904153 atcSuffix "AE02".
- Q904153 casNumber "52757".
- Q904153 drugbank "DB00658".
- Q904153 iupacName "poly".
- Q904153 pubchem "3085017".
- Q904153 unii "941".
- Q904153 type ChemicalSubstance.
- Q904153 type Drug.
- Q904153 type ChemicalObject.
- Q904153 type Thing.
- Q904153 type Q8386.
- Q904153 comment "Sevelamer (rINN) (/sɛˈvɛləmər/ or /sɛˈvɛləmɪər/) is a phosphate binding drug used to treat hyperphosphatemia in patients with chronic kidney disease. When taken with meals, it binds to dietary phosphate and prevents its absorption. Sevelamer was invented and developed by GelTex Pharmaceuticals. Sevelamer is currently marketed by Sanofi under the trade names Renagel (sevelamer hydrochloride) and Renvela (sevelamer carbonate).".
- Q904153 label "Sevelamer".
- Q904153 depiction Sevelamer.png.